Synthesis of (2-[11C]methoxy)rotenone, a marker of mitochondrial complex I activity.

Recent studies suggest that defects in the function of the complexes of the electron transport chain might be involved in the pathology of neurological diseases such as mitochondrial encephalopathies, Parkinson's, Huntington's and Alzheimer's disease. Rotenone is a potent reversible competitive inhibitor of complex I (NADH-CoQ reductase). To study the possible involvement of complex I in such diseases, we synthesized (2-[11C]methoxy)rotenone by [11C]alkylation of 2-O-desmethyl rotenone methyl enol ether followed by hydrolysis of the enol ether to the ketone using aqueous trifluoroacetic acid. (2-[11C]Methoxy)rotenone was purified by high pressure liquid chromatography (silica gel) and was obtained in 7-10% yields decay corrected to end of bombardment in synthesis times typically shorter than 48 min. Radiochemical purities were over 95% and specific activities averaged 1000 Ci/mmol at end of synthesis.

[1]  M. Beal,et al.  Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? , 1992, Annals of neurology.

[2]  N. Savarese,et al.  Respiratory chain and mitochondrial DNA in muscle and brain in Parkinson's disease patients , 1993, Neurology.

[3]  J. Casida,et al.  Interaction of 1‐Methyl‐4‐Phenylpyridinium Ion (MPP+) and Its Analogs with the Rotenone/Piericidin Binding Site of NADH Dehydrogenase , 1991, Journal of neurochemistry.

[4]  G. Hofhaus,et al.  The respiratory-chain NADH dehydrogenase (complex I) of mitochondria. , 1991, European journal of biochemistry.

[5]  C. Marsden,et al.  Anatomic and Disease Specificity of NADH CoQ1 Reductase (Complex I) Deficiency in Parkinson's Disease , 1990, Journal of neurochemistry.

[6]  B. Hyman,et al.  Do defecs in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? , 1993, Trends in Neurosciences.

[7]  S. Dimauro,et al.  Mitochondria1 involvement in Parkinson's disease , 1993, Neurology.

[8]  R. S. Burns,et al.  Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism , 1984, Nature.

[9]  C. Marín,et al.  Mitochondria1 respiratory chain activity in skeletal muscle from patients with Parkinson's disease , 1993, Neurology.

[10]  S. Bondy,et al.  The relationship between excitotoxicity and oxidative stress in the central nervous system. , 1993, Free radical biology & medicine.

[11]  S. Boyson.  Parkinson's disease and the electron transport chain , 1991, Annals of neurology.

[12]  J. Casida,et al.  Studies on the respiratory chain-linked reduced nicotinamide adenine dinucleotide dehydrogenase. XVII. Reaction sites of piericidin A and rotenone. , 1970, The Journal of biological chemistry.

[13]  J. Parks,et al.  Abnormalities of the electron transport chain in idiopathic parkinson's disease , 1989, Annals of neurology.

[14]  A. Lehninger.  Principles of Biochemistry , 1984 .

[15]  T. E. Goodwin,et al.  4-Formyl-2-cyclohexenone Derivatives , 1978 .

[16]  D. Higgins,et al.  Quantitative Autoradiography of Dihydrorotenone Binding to Complex I of the Electron Transport Chain , 1992, Journal of neurochemistry.

[17]  D. Calne.  The free radical hypothesis in idiopathic parkinsonism: Evidence against it , 1992, Annals of neurology.

[18]  L. Crombie,et al.  The rotenoid core structure: Modifications to define the requirements of the toxophore. , 1992 .

[19]  I. Silver,et al.  ATP and Brain Function , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[20]  S. Fahn,et al.  The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it , 1992, Annals of neurology.

[21]  C. Marsden,et al.  Mitochondrial function in Parkinson's disease , 1992 .

[22]  L. Crombie,et al.  Regioselective ether cleavages of rotenoids: spiro-ether formation and stereoselective isotopic labelling of (E)- or (Z)-prenyl methyl groups in (6aS, 12aS)-rot-2′-enonic acid , 1982 .

[23]  H. Nakamura,et al.  Studies on the respiratory chain-linked reduced nicotinamide adenine dinucleotide dehydrogenase. XVI. Characteristics of the membrane-bound dehydrogenase in Candida utilis and Saccharomyces cerevisiae. , 1970, Archives of biochemistry and biophysics.

[24]  L. Crombie.  Rotenoids and their biosynthesis , 1984 .